IPA (ImmunoPrecise Antibodies)

ImmunoPrecise Antibodies (IPA) is a global biotherapeutic company headquartered in Victoria, BC, Canada, with additional offices in the United States and Europe. IPA specializes in antibody discovery and development, providing a comprehensive suite of services to pharmaceutical and biotechnology companies. They offer a unique combination of wet lab and in silico technologies, including their proprietary LENSai platform, which uses artificial intelligence to accelerate antibody discovery and optimize antibody selection and engineering. Their commitment to innovation and technological advancement has led them to be ranked as a top antibody discovery CRO by industry analysts.

IPA's mission is to lead its partners into the era of the antibody, leveraging its expertise and cutting-edge technologies to deliver the most therapeutically relevant antibodies in a shorter period of time. They are dedicated to developing innovative and effective therapies for a wide range of diseases. IPA's global reach, strong track record, and commitment to excellence have made them a trusted partner for companies seeking to bring new antibody-based therapies to market.

IPA offers flexible work schedules as a benefit to its employees, though the specific details may vary based on the location of the position. This suggests a degree of flexibility, allowing employees to potentially adjust their work hours or days to meet personal needs. However, the website doesn't elaborate on the extent of this flexibility or whether other options like remote work are offered.

IPA offers a comprehensive benefits package including medical, dental, and vision insurance, retirement benefits, a health savings account, life and disability insurance, and a flexible work schedule, as well as holiday pay. Benefits may vary based on the location of the position.

ImmunoPrecise Antibodies (IPA) is a biotherapeutic research company that aims to lead its pharmaceutical partners into the era of the antibody by bringing together industry-leading antibody discovery services and complex artificial intelligence technologies. Their mission is to provide highly specialized, full-continuum therapeutic antibody discovery and development, with in silico machine intelligence designed to solve the unique challenges big data processing poses to pharmaceutical companies.

IPA cultivates a culture built on innovation, collaboration, and ownership. Employees are encouraged to be results-driven, work as a team, and treat each other with respect. The company values are Striving, Teamwork, Respectful, Innovative, Visionary, and Excellence, promoting a supportive environment where creative problem-solving and a commitment to excellence are key. This is reflected in their diverse team, flexible work schedules, and commitment to promoting diversity and inclusion.

ImmunoPrecise Antibodies is committed to fostering a diverse and inclusive work environment, recognizing that a diverse team operating in an inclusive setting is key to generating forward-thinking, unique, and productive solutions. This commitment is reflected in the company's representation in leadership roles and advertisements, aiming to ensure employees and clients feel comfortable and empowered to contribute their unique perspectives. IPA's values, STRIVE (Striving, Teamwork, Respectful, Innovative, Visionary, Excellence), underscore a culture of respect, collaboration, and continuous improvement, embracing differences in age, ethnicity, gender, ability, and other characteristics. This commitment extends to the company's practices and policies, encompassing recruitment, compensation, development, promotion, and social programs, all designed to create a work environment that promotes respectful communication, teamwork, and work-life balance.